FGFR3 and achondroplasia: The prevalence of ACH is estimated to range from 1 in 10,000 to 30,000 individuals, with more than 98% of patients presenting a point mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which is located on chromosome 4p16.3 [2, 4, 5].